RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1999; 82(06): 1778
DOI: 10.1055/s-0037-1614920
DOI: 10.1055/s-0037-1614920
Letters to the Editor
Successful Epistaxis Control in a Patient with Glanzmann Thrombasthenia by Increased Bolus Injection Dose of Recombinant Factor VIIa
Weitere Informationen
Publikationsverlauf
Received
06. Juli 1999
Accepted
10. August 1999
Publikationsdatum:
10. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199906/lookinside/thumbnails/10-1055s-0037-1614920-1.jpg)
-
References
- 1 Kristensen J, Killander A, Hippe E. et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 01) 159-64.
- 2 Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost (letter) 1996; 75: 981-2.
- 3 Revesz T, Arets B, Bierings M, Bos CVD, Duval E. Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost (letter) 1998; 80: 353.
- 4 Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-7.
- 5 Hoffman M, Monroe III DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coag Fibrinol 1998; 9 (Suppl. 01) S61-5.